Carmelo De Grazia Suárez Milford// New Johns Hopkins research center tests psychedelics to treat mental health - EntornoInteligente
Entornointeligente.com /

Johns Hopkins Medicine is launching a new psychedelic research center where scientists will test the potential of “magic mushrooms” and other drugs to treat some of the toughest mental health and addiction challenges.

Carmelo De Grazia

The center is believed to be the first center in the United States and the largest in the world to focus on drugs still better known as symbols of 1960s counterculture than serious medicine.

Carmelo De Grazia Suárez

The Center for Psychedelic and Consciousness Research at Johns Hopkins Medicine in Baltimore is being funded by a $17 million donation from a group of private donors. Because federal funding cannot be used for such research, the center needs private support

The center’s research will focus on applications of the drugs for treating opioid addiction, Alzheimer’s disease, post-traumatic stress disorder, eating disorders and depression, among other diseases

Psychedelics are a fascinating class of compounds,” said Roland Griffiths, the center’s director and a professor of behavioral biology in the Hopkins School of Medicine

They produce unique and profound change in consciousness,” he said. “The center will allow us to expand on research to develop new treatments for a wide variety of psychiatric disorders. And it will allow us to extend on past research in healthy people to improve their sense of well being.”

“Johns Hopkins is deeply committed to exploring innovative treatments for our patients,” Paul B. Rothman, chief executive of Johns Hopkins Medicine and dean of the medical school’s faculty, said in a statement. “Our scientists have shown that psychedelics have real potential as medicine, and this new center will help us explore that potential.”

Psilocybin and MDMA are illegal drugs in the United States classified by the federal government along with heroin and cocaine. Laws relating to salvia vary by state, but it’s illegal in most states

But researchers at Hopkins and elsewhere have said such drugs could help in areas of pain, addiction and brain disorders

The center is being funded by the Steven & Alexandra Cohen Foundation and philanthropists who include Tim Ferriss, an author and technology investor; Matt Mullenweg, co-founder of WordPress; Blake Mycoskie, founder of the shoe company TOMS; and Craig Nerenberg, an investor

Ferriss said his interest in the drugs is personal. There is depression and brain disease among family members, and a good friend died of a drug overdose. He said his contribution, between $2 million and $3 million, is the largest investment he has made in a corporate or nonprofit endeavor

He said he was hoping to “affect the timeline” of federal regulatory approvals for psychedelic drugs, though he opposed over-the-counter uses

“Good science takes time,” he said, adding that he wanted to support “unlocking the full potential of productive teams.”

The center will look at how psychedelics affect behavior, brain function, learning and memory, the brain’s biology and mood

The Hopkins researchers said they understood the risks and dangers of using psychedelic drugs that they said were not addictive but could be abused. They said they could control for potential abuse or bad outcomes, such as long-term effects of the drug’s use on those with undiagnosed mental health disorders, in a laboratory setting where people and drugs are carefully screened

The National Institute on Drug Abuse says there are many potential short- and long-term harms from hallucinogens. Users can see, hear and feel things that don’t exist, experiences that can be unpleasant, known as a “bad trip.”

Users can suffer increased heart rate and blood pressure, nausea, intensified feelings, loss of appetite, sleep problems, excessive sweating and panic, though others may have intense spiritual experiences and feelings of relaxation. Users also can be a danger if they drive

Over time, according to the drug abuse institute, users can suffer persistent psychosis, visual disturbances, disorganized thinking, paranoia and mood changes, among other problems

The institute said people can overdose on some hallucinogens, such as PCP, though serious medical emergencies are not common and not associated with drugs typically used in the research studies. Drugs also can be contaminated, and those trying to use psilocybin could consume poisonous mushrooms that look like the ones containing the compound

There are not currently any federally approved psychedelic drugs for medicinal purposes

The field is chock full of lessons, and we take them seriously,” said Matthew Johnson, an associate professor of psychiatry and behavioral sciences in the medical school, who is the center’s assistant director. But he said the potential benefits could be enormous

The rate of fatal opioid overdoses will probably make use of psilocybin more acceptable to the public, after a “war on drugs” in the 1970s and ’80s stymied all research into psychedelic substances for decades, said Sara Lappan, a visiting instructor in the counseling program at the University of Alabama at Birmingham’s department of human studies

Lappan is working on a study using psilocybin to treat addiction to cocaine, a drug that has been making a comeback among users after years of declines. The Alabama study is among a handful around the country testing psilocybin for a variety of treatments

That study aims to give people “the ability to change” because of how they view themselves. It’s like giving them “10 years of therapy smashed into six hours,” she said

Researchers, she said, hope eventually to use their scientific data to change the legal status of the drug, though she said she knew of no researcher who wants recreational use of psilocybin. And she agreed that the studies have shown promise because the participants and the substances are carefully screened

At Hopkins, the funding is expected to support five years of research and a team of six faculty neuroscientists, experimental psychologists and clinicians

Entornointeligente.com

Advertisement

Nota de Prensa VIP

Smart Reputation